Free Trial

Virtus LifeSci Biotech Products ETF (BBP) Holdings List

$101.80 +1.09 (+1.08%)
Closing price 04:10 PM Eastern
Extended Trading
$101.80 0.00 (0.00%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does BBP hold?

The Virtus LifeSci Biotech Products ETF (BBP) has 71 holdings, with Moderna, Iovance Biotherapeutics, and Omeros among its largest positions. The top 25 BBP holdings ordered by weight make up 51.31% of the total fund. BBP is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete BBP stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 BBP Holdings

RankCompanyCurrent PriceWeightShares Held
1
Moderna, Inc. stock logo
MRNA
Moderna
$226.30
+4.6%
5.31%33,770
2
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$14.21
-2.0%
4.52%413,111
3
Omeros Corporation stock logo
OMER
Omeros
$18.43
-2.4%
2.82%192,959
4
Verastem, Inc. stock logo
VSTM
Verastem
$7.71
+3.5%
2.55%411,097
5
Precigen, Inc. stock logo
PGEN
Precigen
$7.36
-1.6%
2.27%378,763
6
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$116.82
+6.6%
2.03%24,252
7
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
$22.50
-2.6%
1.96%98,741
8
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
$9.77
-4.2%
1.95%248,233
9
Kiniksa Pharmaceuticals International, plc stock logo
KNSA
Kiniksa Pharmaceuticals International
$78.84
+0.4%
1.92%32,483
10
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$9.91
+1.1%
1.91%237,394
11
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$46.82
-0.7%
1.90%51,309
12
Novavax, Inc. stock logo
NVAX
Novavax
$12.64
-1.4%
1.85%189,808
13
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$351.48
+0.7%
1.78%6,373
14
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
$136.28
-1.6%
1.67%15,354
15
ADMA Biologics Inc stock logo
ADMA
ADMA Biologics
$10.34
+0.3%
1.61%205,298
16
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
$72.29
+2.1%
1.57%27,207
17
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
$294.99
-2.8%
1.57%6,595
18
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$33.62
+0.8%
1.55%56,108
19
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$778.36
+3.4%
1.55%2,753
20
Kura Oncology, Inc. stock logo
KURA
Kura Oncology
$9.61
-2.2%
1.53%186,243
21
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
$37.51
+1.3%
1.51%48,911
22
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$153.54
+3.8%
1.50%13,420
23
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$50.22
+0.2%
1.50%33,845
24
Zymeworks Inc. stock logo
ZYME
Zymeworks
$24.77
-1.2%
1.49%73,667
25
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$16.83
+1.9%
1.49%110,091

BBP Geographic Exposure

BBP's largest geographic exposure is United States at 93.5%, followed by United Kingdom at 2.0%.

  • United States
    93.5%
  • United Kingdom
    2.0%
  • Bermuda
    1.5%
  • Canada
    1.4%
  • Switzerland
    1.3%

BBP Currency Exposure

BBP is exclusively exposed to USD.

  • USD
    100.0%

BBP Sector Exposure

BBP's largest sector exposure is Health Care at 98.4%.

  • Health Care
    98.4%

BBP Industry Exposure

BBP's largest industry exposure is Biotechnology at 91.2%, followed by Pharmaceuticals at 7.2%.

  • Biotechnology
    91.2%
  • Pharmaceuticals
    7.2%

BBP Sub-Industry Exposure

BBP's largest sub-industry exposure is Biotechnology at 83.3%, followed by Pharmaceuticals at 8.0%.

  • Biotechnology
    83.3%
  • Pharmaceuticals
    8.0%

Related Companies and Tools


MarketBeat tracks Virtus LifeSci Biotech Products ETF holdings and portfolio composition, last updated on 10/7/2026.
From Our Partners